SETD2 and nonpapillary renal cell carcinoma: In the previous studies, SETD2 deficiency induced a metabolic switch toward enhanced oxidative phosphorylation in ccRCC, which can be related to peroxisome proliferator-activated receptor γcoactivator-1 (PGC1α)-mediated metabolic networks19.